Trajectory of absolute neutrophil counts in patients treated with pegfilgrastim on the day of chemotherapy versus the day after chemotherapy

PURPOSE: Risk of infection increases with severity and duration of chemotherapy-induced neutropenia (CIN). Pegfilgrastim is approved for use on the day after chemotherapy to reduce incidence of infection, as manifested by febrile neutropenia (FN), in patients receiving myelosuppressive chemotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanli, Klippel, Zandra, Shih, Xiaolong, Wang, Hong, Reiner, Maureen, Page, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819939/
https://www.ncbi.nlm.nih.gov/pubmed/26886017
http://dx.doi.org/10.1007/s00280-016-2970-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819939/
https://www.ncbi.nlm.nih.gov/pubmed/26886017
http://dx.doi.org/10.1007/s00280-016-2970-5

Ejemplares similares